Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis
Clinical trial NCT01414101 · COMPLETED
Trial details
- NCT number
- NCT01414101
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-05-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.